MBP and columnar cell hyperplasia of the breast: By contrast, treatment of ADORA2A inhibitor SCH58261 led to the increased GFAP expression and decreased MBP absorbance, further confirming that ADORA2A could inhibit the activation of astrocytes and reduce the white matter lesions induced by CCH.